1-s2.0-S0002929714004753-main.pdf (1.88 MB)
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1
journal contribution
posted on 2023-06-08, 23:10 authored by D M Glubb, M J Maranian, K Michailidou, K A Pooley, K B Meyer, S Kar, S Carlebur, M O'Reilly, J A Betts, K M Hillman, S Kaufmann, J Beesley, S Canisius, J L Hopper, M C Southey, H Tsimiklis, C Apicella, M K Schmidt, A Broeks, F B Hogervorst, C E Van Der Schoot, K Muir, A Lophatananon, S Stewart-Brown, P Siriwanarangsan, P A Fasching, M Ruebner, A B Ekici, M W Beckmann, J Peto, I Dos-Santos-Silva, O Fletcher, N Johnson, P D P Pharoah, M K Bolla, Q Wang, J Dennis, E J Sawyer, I Tomlinson, M J Kerin, N Miller, B Burwinkel, F Marme, R Yang, H Surowy, P Guénel, T Truong, F Menegaux, M Sanchez, S E Bojesen, B G Nordestgaard, S F Nielsen, H Flyger, A González-Neira, J Benitez, M P Zamora, J I Arias Perez, H Anton-Culver, S L Neuhausen, H Brenner, A K Dieffenbach, V Arndt, C Stegmaier, A Meindl, R K Schmutzler, H Brauch, Y-D Ko, T Brüning, H Nevanlinna, T A Muranen, K Aittomaki, C Blomqvist, K Matsuo, H Ito, H Iwata, H Tanaka, T Dork, N V Bogdanova, S Helbig, A Lindblom, S Margolin, A Mannermaa, V Kataja, V-M Kosma, J M Hartikainen, A H Wu, C-C Tseng, D Van Den Berg, D O Stram, D Lambrechts, H Zhao, C Weltens, E Van Limbergen, J Chang-Claude, D Flesch-Janys, A Rudolph, P Seibold, P Radice, P Peterlongo, M Barile, F Capra, F J Couch, J E Olson, E Hallberg, C Vachon, G G Giles, R L Milne, C McLean, C A Haiman, B E Henderson, F Schumacher, L Le Marchand, J Simard, M S Goldberg, F Labrache, M Dumont, S H Teo, C H Yip, M-H See, B Cornes, C-Y Cheng, M K Ikram, V Kristensen, W Zheng, S L Halverson, M Shrubsole, J Long, R Winqvist, K Pylkas, A Jukkola-Vuorinen, S Kauppila, I L Andrulis, J A Knight, G Glendon, S Tchatchou, P Devilee, R A E M Tollenaar, C Seynaeve, C J Van Asperen, M Garcia-Closas, J Figueroa, S J Chanock, J Lissowska, K Czene, D Klevebring, H Darabi, M Eriksson, M J Hooning, A Hollestelle, J W M Martens, J M Collée, P Hall, J LI, K Humphreys, X-O Shu, W Lu, Y-T Gao, H Cai, A Cox, S S Cross, Malcolm ReedMalcolm Reed, W Blot, L B Signorello, Q Cai, M Shah, M Ghoussaini, D Kang, J-Y Choi, S K Park, D-Y Noh, M Hartman, H Miao, W Y Lim, A Tang, U Hamann, D Torres, A Jakubowska, J Lubinski, K Jaworska, K Durda, S Sangrajrang, V Gaborieau, P Brennan, J McKay, C Olswold, S Slager, A E Toland, D Yannoukakos, C-Y Shen, P-E Wu, J-C Yu, M-F Hou, A Swerdlow, A Ashworth, N Orr, M Jones, G Pita, M R Alonso, N Ãlvarez, D Herrero, D C Tessier, D Vincent, F Bacot, C Luccarini, C Baynes, S Ahmed, C S Healey, M A Brown, B A J Ponder, G Chenevix-Trench, D J Thompson, S L Edwards, D F Easton, A M Dunning, J D FrenchGenome-wide association studies (GWASs) have revealed SNP rs889312 on 5q11.2 to be associated with breast cancer risk in women of European ancestry. In an attempt to identify the biologically relevant variants, we analyzed 909 genetic variants across 5q11.2 in 103,991 breast cancer individuals and control individuals from 52 studies in the Breast Cancer Association Consortium. Multiple logistic regression analyses identified three independent risk signals: the strongest associations were with 15 correlated variants (iCHAV1), where the minor allele of the best candidate, rs62355902, associated with significantly increased risks of both estrogen-receptor-positive (ER+: odds ratio [OR] = 1.24, 95% confidence interval [CI] = 1.21–1.27, ptrend = 5.7 × 10-44) and estrogen-receptor-negative (ER-: OR = 1.10, 95% CI = 1.05–1.15, ptrend = 3.0 × 10-4) tumors. After adjustment for rs62355902, we found evidence of association of a further 173 variants (iCHAV2) containing three subsets with a range of effects (the strongest was rs113317823 [pcond = 1.61 × 10-5]) and five variants composing iCHAV3 (lead rs11949391; ER+: OR = 0.90, 95% CI = 0.87–0.93, pcond = 1.4 × 10-4). Twenty-six percent of the prioritized candidate variants coincided with four putative regulatory elements that interact with the MAP3K1 promoter through chromatin looping and affect MAP3K1 promoter activity. Functional analysis indicated that the cancer risk alleles of four candidates (rs74345699 and rs62355900 [iCHAV1], rs16886397 [iCHAV2a], and rs17432750 [iCHAV3]) increased MAP3K1 transcriptional activity. Chromatin immunoprecipitation analysis revealed diminished GATA3 binding to the minor (cancer-protective) allele of rs17432750, indicating a mechanism for its action. We propose that the cancer risk alleles act to increase MAP3K1 expression in vivo and might promote breast cancer cell survival.
History
Publication status
- Published
File Version
- Published version
Journal
American Journal of Human GeneticsISSN
0002-9297Publisher
Cell PressExternal DOI
Issue
1Volume
96Page range
5-20Department affiliated with
- BSMS Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2016-03-16First Open Access (FOA) Date
2016-03-16First Compliant Deposit (FCD) Date
2016-03-16Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC